Lidocaine Hydrochloride Injection, Solution
Product Images NDC 76420-540

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 76420-540). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (Lidocaine Fig1)

Package Label-principal Display Panel (Lidocaine Fig1)
Lidocaine Hydrochloride Injection, USP 2% (100 mg/5 mL) vial label. The label shows NDC 76420-540-05, distributed by AuroMedics Pharma LLC and relabeled by EnovaChem Pharmaceuticals. The vial contains 5 mL of a clear, colorless solution intended for epidural, infiltration, intracaudal, and perineural use. The label includes cautionary storage instructions and federal dispensing warnings.*
FDA Label Image

Lidocaine Hydrochloride Chemical Structure (Lidocaine Str)

Lidocaine Hydrochloride Chemical Structure (Lidocaine Str)
Chemical structure diagram of Lidocaine Hydrochloride showing its molecular components, including a benzene ring with two methyl groups, an amide linkage, and a diethylamino group attached to the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.